DECIPHERA PHARMACEUTICALS IN (DCPH) Stock Analyst Ratings
NASDAQ:DCPH - Nasdaq - US24344T1016 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 71% to DCPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.25. This target is 6.47% above the current price.
DCPH was analyzed by 16 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about DCPH.
In the previous month the buy percentage consensus was at a similar level.
DCPH was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-30 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-04-30 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-04-30 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2024-04-29 | JonesTrading | Downgrade | Buy -> Hold |
| 2024-04-29 | Jefferies | Downgrade | Buy -> Hold |
| 2024-03-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-07 | Stifel | Maintains | Buy -> Buy |
| 2023-11-20 | JP Morgan | Reiterate | Neutral |
| 2023-10-31 | JonesTrading | Upgrade | Hold -> Buy |
| 2023-10-31 | Stifel | Maintains | Buy -> Buy |
| 2023-10-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-30 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-08-10 | Stifel | Upgrade | Hold -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | JMP Securities | Reiterate | Market Outperform |
| 2023-05-04 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-15 | JMP Securities | Reiterate | Market Outperform |
| 2023-02-08 | SVB Leerink | Reiterate | Outperform |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-07 | SVB Leerink | Maintains | Outperform |
| 2023-01-25 | Cowen & Co. | Maintains | Outperform |
| 2023-01-06 | JonesTrading | Upgrade | Sell -> Hold |
| 2023-01-04 | Guggenheim | Upgrade | Neutral -> Buy |
| 2023-01-04 | SVB Leerink | Maintains | Outperform |
| 2023-01-04 | Barclays | Maintains | Underweight |
| 2022-09-27 | Stifel | Maintains | Hold |
| 2022-09-12 | SVB Leerink | Maintains | Outperform |
| 2022-09-12 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-29 | Cowen & Co. | Initiate | Outperform |
| 2022-08-05 | JMP Securities | Upgrade | Market Perform -> Market Outperform |